| Identification | Back Directory | [Name]
Phenylalanine,4-[bis(2-chloroethyl)amino]-N-formyl-
| [CAS]
26367-45-3 | [Synonyms]
N-Formylsarcolysine
Phenylalanine,4-[bis(2-chloroethyl)amino]-N-formyl- | [Molecular Formula]
C14H18Cl2N2O3 | [MOL File]
26367-45-3.mol | [Molecular Weight]
333.21 |
| Chemical Properties | Back Directory | [Melting point ]
148-150 °C(Solv: methanol (67-56-1)) | [Boiling point ]
580.1±50.0 °C(Predicted) | [density ]
1.331±0.06 g/cm3(Predicted) | [pka]
3.18±0.10(Predicted) |
| Hazard Information | Back Directory | [Uses]
N-Formylsarcolysine has antitumor activity, and inhibits leukemia by increasing the Hb and erythrocyte levels and decreasing the number of leukocytes. N-Formylsarcolysine also involves in glioblastoma and other diseases research[1][2]. | [References]
[1] HAN J, et al. [STUDIES ON ANTITUMOR DRUGS. VII. STUDIES ON THE ANTITUMOR SPECTRUM AND TOXICITY OF N-FORMYLSARCOLYSINE]. Yao Xue Xue Bao. 1964 May;11:330-7. Chinese. PMID:14181135
[2] ChenYY, et al. Quinoline derivative for treating glioblastoma: China, CN112294814[P]. 2021-02-02. |
|
|